Erytech Pharma SA Executives

ERYPDelisted Stock  USD 0.78  0.04  4.88%   
Erytech Pharma employs about 49 people. The company is managed by 10 executives with a total tenure of roughly 9 years, averaging almost 0.0 years of service per executive, having 4.9 employees per reported executive. Discussion of Erytech Pharma's management performance can provide insight into the enterprise performance.
  
Check out Investing Opportunities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in manufacturing.

Erytech Pharma Management Team Effectiveness

The company has return on total asset (ROA) of (0.3014) % which means that it has lost $0.3014 on every $100 spent on assets. This is way below average. Erytech Pharma's management efficiency ratios could be used to measure how well Erytech Pharma manages its routine affairs as well as how well it operates its assets and liabilities.

Erytech Pharma Workforce Comparison

Erytech Pharma SA is rated # 4 in number of employees category among its peers. The total workforce of Health Care industry is currently estimated at about 696. Erytech Pharma holds roughly 49.0 in number of employees claiming about 7% of equities under Health Care industry.
The company has Profit Margin (PM) of (0.03) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (4.08) %, which suggests for every $100 dollars of sales, it generated a net operating loss of $4.08.

Erytech Pharma Notable Stakeholders

An Erytech Pharma stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Erytech Pharma often face trade-offs trying to please all of them. Erytech Pharma's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Erytech Pharma's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
Eric SoyerCFO, COOProfile
Gil BVBACEO DirectorProfile
Iman MDChief OfficerProfile
Philip LorenziConsultant BoardProfile
AnneCcile FumeyHR DirectorProfile
Brian SchwabChief CounselProfile
Naomi EichenbaumDirector RelationsProfile
Bridget BaxConsultant BoardProfile
Jrme PharmDChief OperationsProfile
Pr MDConsultant BoardProfile

About Erytech Pharma Management Performance

The success or failure of an entity such as Erytech Pharma SA often depends on how effective the management is. Erytech Pharma management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Erytech management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Erytech management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
ERYTECH Pharma S.A., a clinical-stage biopharmaceutical company, develops red blood cell-based therapeutics for cancer and orphan diseases in France and the United States. The company was incorporated in 2004 and is headquartered in Lyon, France. Erytech Pharma operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 149 people.

Erytech Pharma Workforce Analysis

Traditionally, organizations such as Erytech Pharma use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Erytech Pharma within its industry.

Erytech Pharma Manpower Efficiency

Return on Erytech Pharma Manpower

Revenue Per Employee0.0
Revenue Per Executive0.0
Net Loss Per Employee4.7K
Net Loss Per Executive22.8K
Working Capital Per Employee631.8K
Working Capital Per Executive3.1M
Check out Investing Opportunities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in manufacturing.
You can also try the Portfolio Manager module to state of the art Portfolio Manager to monitor and improve performance of your invested capital.

Other Consideration for investing in Erytech Stock

If you are still planning to invest in Erytech Pharma SA check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Erytech Pharma's history and understand the potential risks before investing.
Portfolio Dashboard
Portfolio dashboard that provides centralized access to all your investments
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Sign In To Macroaxis
Sign in to explore Macroaxis' wealth optimization platform and fintech modules
Technical Analysis
Check basic technical indicators and analysis based on most latest market data
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
Economic Indicators
Top statistical indicators that provide insights into how an economy is performing